Overview

Betaferon® Regulatory Post-Marketing Surveillance

Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
To identify problems/questions about following items in the clinical practice using Betaferon 1. Unknown adverse event (especially serious adverse event) 2. Identification of adverse event occurred in the real practice 3. Factors that may affect the safety of drug 4. Factors that may affect the effectiveness of the drug
Details
Lead Sponsor:
Bayer
Treatments:
Interferon beta-1b
Interferon-beta
Interferons